205 related articles for article (PubMed ID: 37789721)
1. New and emerging options for management of invasive fungal diseases in paediatric patients.
Groll AH; Körholz K; Holterhus M; Lehrnbecher T
Mycoses; 2024 Jan; 67(1):e13654. PubMed ID: 37789721
[TBL] [Abstract][Full Text] [Related]
2. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
Fera MT; La Camera E; De Sarro A
Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
[TBL] [Abstract][Full Text] [Related]
3. Antifungal chemoprophylaxis in children and adolescents with haematological malignancies and following allogeneic haematopoietic stem cell transplantation: review of the literature and options for clinical practice.
Tragiannidis A; Dokos C; Lehrnbecher T; Groll AH
Drugs; 2012 Mar; 72(5):685-704. PubMed ID: 22413762
[TBL] [Abstract][Full Text] [Related]
4. Echinocandins: role in antifungal therapy, 2005.
Zaas AK; Alexander BD
Expert Opin Pharmacother; 2005 Aug; 6(10):1657-68. PubMed ID: 16086652
[TBL] [Abstract][Full Text] [Related]
5. Experiences with the use of caspofungin in paediatric patients.
Lehrnbecher T; Groll AH
Mycoses; 2008; 51 Suppl 1():58-64. PubMed ID: 18471162
[TBL] [Abstract][Full Text] [Related]
6. Update on antifungal agents for paediatric patients.
Groll AH; Tragiannidis A
Clin Microbiol Infect; 2010 Sep; 16(9):1343-53. PubMed ID: 20678177
[TBL] [Abstract][Full Text] [Related]
7. Echinocandin antifungal drugs in fungal infections: a comparison.
Chen SC; Slavin MA; Sorrell TC
Drugs; 2011 Jan; 71(1):11-41. PubMed ID: 21175238
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of anti-fungal agents for invasive fungal infection prophylaxis in liver transplant recipients: A network meta-analysis.
Liu Y; Lan C; Qin S; Qin Z; Zhang Z; Zhang P; Cao W
Mycoses; 2022 Oct; 65(10):906-917. PubMed ID: 35899464
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, utilisation of healthcare resources and outcome of invasive fungal diseases following paediatric allogeneic haematopoietic stem cell transplantation.
Linke C; Ehlert K; Ahlmann M; Fröhlich B; Mohring D; Burkhardt B; Rössig C; Groll AH
Mycoses; 2020 Feb; 63(2):172-180. PubMed ID: 31661569
[TBL] [Abstract][Full Text] [Related]
10. Antifungal therapy for invasive fungal diseases in allogeneic stem cell transplant recipients: an update.
Wilson DT; Drew RH; Perfect JR
Mycopathologia; 2009 Dec; 168(6):313-27. PubMed ID: 19308672
[TBL] [Abstract][Full Text] [Related]
11. Challenges in the Treatment of Invasive Aspergillosis in Immunocompromised Children.
Hsu AJ; Tamma PD; Fisher BT
Antimicrob Agents Chemother; 2022 Jul; 66(7):e0215621. PubMed ID: 35766509
[TBL] [Abstract][Full Text] [Related]
12. New antifungal agents.
Gupta AK; Tomas E
Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208
[TBL] [Abstract][Full Text] [Related]
13. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Moen MD; Lyseng-Williamson KA; Scott LJ
Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
[TBL] [Abstract][Full Text] [Related]
14. Newer antifungal agents for invasive fungal infections in patients with haematological malignancy.
Rogers TR; Frost S
Br J Haematol; 2009 Mar; 144(5):629-41. PubMed ID: 19120371
[TBL] [Abstract][Full Text] [Related]
15. The changing face of epidemiology of invasive fungal disease in Europe.
Lass-Flörl C
Mycoses; 2009 May; 52(3):197-205. PubMed ID: 19391253
[TBL] [Abstract][Full Text] [Related]
16. Echinocandins: The Expanding Antifungal Armamentarium.
Aguilar-Zapata D; Petraitiene R; Petraitis V
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S604-11. PubMed ID: 26567277
[TBL] [Abstract][Full Text] [Related]
17. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation.
Groll AH; Castagnola E; Cesaro S; Dalle JH; Engelhard D; Hope W; Roilides E; Styczynski J; Warris A; Lehrnbecher T; ; ; ; ;
Lancet Oncol; 2014 Jul; 15(8):e327-40. PubMed ID: 24988936
[TBL] [Abstract][Full Text] [Related]
18. A clinical review of echinocandins in pediatric patients.
VandenBussche HL; Van Loo DA
Ann Pharmacother; 2010 Jan; 44(1):166-77. PubMed ID: 20009006
[TBL] [Abstract][Full Text] [Related]
19. Experience with anidulafungin in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease.
Yáñez L; Insunza A; Ibarrondo P; de Miguel C; Bermúdez A; Colorado M; López-Duarte M; Richard C; Conde E
Transpl Infect Dis; 2015 Oct; 17(5):761-7. PubMed ID: 26250790
[TBL] [Abstract][Full Text] [Related]
20. Clinical indications for newer antifungal agents.
Naeger-Murphy N; Pile JC
J Hosp Med; 2009 Feb; 4(2):102-11. PubMed ID: 19219926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
